Clinical trial
Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
NCT01686191 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- December 31, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic renal insufficiency, heart transplantation